(137 days)
Punctum plugs are indicated for the treatment of dry eye disorder. A condition caused by insufficient moisture in the eye. As a result, one may experience some irritation and discomfort to the eyes. Patients that may benefit from the use of punctum plugs are: sufferers of allergies, cataracts, dry eye disorder secondary to contact lens use, and others who experience dry eye disorders. Specific treatment to stop the outflow of tears via a punctal opening (upper/lower) in order to increase tear flow on the surface of the eye.
Not Found
This FDA letter is a 510(k) premarket notification for the Delta Punctum Plug, a medical device. This type of document primarily confirms that a new device is substantially equivalent to existing legally marketed predicate devices, allowing it to proceed to market. It typically does not contain the kind of detailed study information (acceptance criteria, specific performance metrics, sample sizes, ground truth establishment, etc.) that would be found in a clinical study report or a more comprehensive regulatory submission.
Therefore,Based on the provided text, I cannot answer the questions regarding acceptance criteria and the study proving the device meets those criteria. The document is a 510(k) clearance letter, which confirms substantial equivalence to a predicate device but does not detail performance studies or specific acceptance criteria for a new device's performance.
To answer these questions, I would need access to the actual 510(k) submission packet, which would include performance data, test methods, and acceptance criteria if such information was required for the substantial equivalence determination for this particular device (e.g., if it involved novel technology or significant design changes that necessitated new performance testing).
{0}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 1 9 2005
Delta Life Sciences, Inc. c/o Mr. George W. Murray 1975 Nonconnah Blvd. Memphis, TN 38132
Re: K050851
Trade/Device Name: Delta Punctum Plug Regulatory Class: Unclassified Product Code: LZU Dated: August 3, 2005 Received: August 4, 2005
Dear Mr. Murray:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Scctions 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally
{1}------------------------------------------------
Page 2 – Mr. George W. Murray
marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 827-8910. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours.
David M. Whipple
David M. Whipple Acting Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Page 3 - Mr. George W. Murray
Indications for Use
510(k) Number: K050851
Device Name: Delta Punctum Plug
Indications For Use:
Punctum plugs are indicated for the treatment of dry eye disorder. A condition caused by insufficient moisture in the eye. As a result, one may experience some irritation and discomfort to the eyes. Patients that may benefit from the use of punctum plugs are: sufferers of allergies, cataracts, dry eye disorder secondary to contact lens use, and others who experience dry eye disorders. Specific treatment to stop the outflow of tears via a punctal opening (upper/lower) in order to increase tear flow on the surface of the eye.
Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Mercury
(Division Sign-Off) Division of Ophthalmic E Nose and Throat Devis
Page 1 of
510(k) Number ________________________________________________________________________________________________________________________________________________________________
N/A